Hosted by Dr. Kesha Chauhan, MD · EN · 31 episodes
Established thought leaders with verified media credentials.
The Leaders in Life Sciences podcast features daily news, strategies, interviews with healthcare professionals, and life science executives. This show is for commercial and medical leaders who want to stay up to date and inspired in their daily work. Hosted on Acast. See acast.com/privacy for more information.
Dr. Kesha Chauhan, MD hosts Leaders in Life Sciences, a science show with 31 episodes published.
Glenmark Pharmaceuticals has recalled nearly 1.5 million bottles of generic atomoxetine (ADHD medication) due to unacceptable levels of a potential carcinogen, N-nitroso atomoxetine. This recall, from January 2024, adds
Novo Nordisk is strategically expanding into rare diseases, shifting from its traditional focus on common chronic conditions, by significantly increasing R&D investment and executing key acquisitions to build a strong po
The FDA is updating the labeling for all FDA-approved testosterone products (oral, topical gel, transdermal patch, buccal system, and injection) based on the TRAVERSE trial and ABPM studies. The results of the TRAVERSE t
A study by Phreesia demonstrated that point-of-care messaging significantly increases vaccine uptake. Patients who received vaccine information prior to their appointments were more than twice as likely to get vaccinated
In 2024, Moderna faced financial challenges including $739 million in cost of sales for the fourth quarter, which factored in $193 million in inventory write-downs, $259 million in production wind-down costs, and a $238
Hosted on Acast. See acast.com/privacy for more information.
The pharmaceutical and life sciences sector anticipates a surge in merger and acquisition activity in 2025. Driving this trend are expected interest rate reductions by the Federal Reserve and the resolution of post-elect
Hosted on Acast. See acast.com/privacy for more information.
The FDA is alerting the public to the risk of anaphylaxis, a rare but serious allergic reaction, associated with glatiramer acetate (Copaxone, Glatopa), a drug used to treat multiple sclerosis (MS). Anaphylaxis can occur
Novo Nordisk, known for its obesity drugs Ozempic and Wegovy, reported strong profit and revenue for 2024, surpassing Wall Street expectations. However, the company expects slower sales growth in 2025 due to rising compe
Pfizer is heavily investing in its experimental obesity drug, danuglipron, aiming for a once-daily oral pill to compete with the currently dominant injectable weight-loss treatments from Eli Lilly and Novo Nordisk. CEO A
Swoop, an AI-driven healthcare marketing business, acquired MyHealthTeam, a company that runs condition-specific online patient communities1. MyHealthTeam has over 60 communities, some with over 100,000 members, focused
The FDA will require GSK and Pfizer to include a warning about the risk of Guillain-Barré syndrome (GBS) on the labels of their RSV vaccines, Arexvy and Abrysvo, respectively. This decision was made after a postmarketing
The future of pharmaceutical marketing is poised for significant change, driven by technological advancements, a focus on the patient, and sustainability. The integration of cutting-edge technologies like AI, machine lea
The FDA has approved Ensacove (ensartinib), a new second-generation ALK inhibitor, as a first-line treatment for ALK-positive non-small cell lung cancer (NSCLC) in patients who have not previously received an ALK inhibit
The FDA initially authorized COVID-19 tests through Emergency Use Authorizations (EUAs) to facilitate their rapid deployment during the pandemic. These tests can continue to be used as long as they are available and not
The pharmaceutical industry is facing significant challenges and must undergo a bold reinvention to ensure its future success. The sector's shareholder returns have been lagging behind the broader market, with a dispropo
Citius Oncology is preparing to launch LYMPHIR™, a novel treatment for cutaneous T-cell lymphoma (CTCL), and is simultaneously exploring strategic options to maximize its market impact. These options include partnerships
Johnson & Johnson's Rybrevant and Lazcluze drug combination shows significant improvement in overall survival for patients with EGFR-mutated non-small cell lung cancer compared to the current standard treatment, Tagrisso
This podcast episode discusses Ozempic (semaglutide), a GLP-1 receptor agonist initially used for type 2 diabetes, now gaining popularity for weight loss. The episode details its mechanism of action, effectiveness (showi
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Leaders in Life Sciences has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Leaders in Life Sciences is hosted by Dr. Kesha Chauhan, MD. The show is categorised under science (life) and has published 31 episodes.
Leaders in Life Sciences has published 31 episodes.
Leaders in Life Sciences regularly covers science, life, health. It sits in the science category, with a life focus.
Leaders in Life Sciences is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Leaders in Life Sciences hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Leaders in Life Sciences average 8 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Leaders in Life Sciences's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 7 days ago.
